Topical Imiquimod Therapy for Localized Solar Dermatitis in a Dog.

Top Companion Anim Med

Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, University of Georgia, Athens, GA, USA. Electronic address:

Published: September 2022

AI Article Synopsis

  • Chronic sun exposure can cause solar dermatitis in dogs, leading to skin issues like redness, hair loss, and blisters, as seen in a 5-year-old American Bulldog.
  • Histological examination showed significant skin changes such as keratinocyte dysplasia and follicular cysts, confirming the diagnosis of solar dermatitis.
  • The treatment involved antibiotics and imiquimod cream, with imiquimod showing effectiveness in reducing skin inflammation, marking its first reported successful use for this condition in dogs.

Article Abstract

Chronic sun exposure in dogs can result in clinical changes in the skin referred to as solar or actinic dermatitis. A 5-year-old, neutered male, American Bulldog presented with localized unilateral erythematous macules, plaques, alopecia, comedones and hemorrhagic bullae involving the non-pigmented skin on left lateral ventral flank area. The presence of hyperplastic epidermis with keratinocyte dysplasia, superficial dermal elastosis, and multiple follicular cysts with occasional rupture (furunculosis) on histology, together with history and characteristic skin lesions was consistent solar dermatitis/actinic keratosis. Skin scrapings were negative and treatment for secondary pyoderma was initiated with oral clindamycin for 8 weeks. After 2 months of antibiotic therapy, the hemorrhagic bullae resolved; however, erythematous solar/actinic skin lesions with induration and comedones persisted. Topical application of imiquimod 5% cream 3 times weekly for 8 weeks resulted in the resolution of erythema, but some of the non-inflamed comedones remained. Staining for elastin and Ki67 revealed keratinocyte hyperplasia in hair follicle infundibulums and alterations in the elastic fibers around follicles, which may lead to closure and formation of follicular cysts. Imiquimod has been long suggested as a treatment option for solar dermatitis, but this is the first known case report detailing its efficacy in dogs.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tcam.2022.100673DOI Listing

Publication Analysis

Top Keywords

solar dermatitis
8
hemorrhagic bullae
8
follicular cysts
8
skin lesions
8
skin
5
topical imiquimod
4
imiquimod therapy
4
therapy localized
4
solar
4
localized solar
4

Similar Publications

Introduction: The sun is one of the primary natural sources of ultraviolet radiation (UVR) and a known human carcinogen. It has been related to melanoma and several skin cancers, such as squamous cell carcinoma and basal cell carcinoma. Non-melanoma skin cancers are prevalent in South Africa, with high reported incidence rates in both genders.

View Article and Find Full Text PDF

Background/objectives: Skin cancer is becoming increasingly common due to increasing risk factors such as excessive ultraviolet (UV) radiation, genetic predisposition, fair skin, and a history of sunburn. Melanoma accounts for only 1% of cases but causes most skin cancer deaths. Dysplastic nevi (DN) are important precursors of melanoma.

View Article and Find Full Text PDF

Background: Skin cancer prevention relies on effective sun safety practices. Previous studies have shown that LGBTQ+ individuals exhibit lower sunscreen use and higher tanning bed usage compared to their non-LGBTQ+ counterparts. This study is the first to assess skin cancer risk factors, sun-protective behaviors, and skin cancer concerns among LGBTQ+ individuals across Canada.

View Article and Find Full Text PDF

Background: The skin barrier plays a crucial role in protecting our body against external agents. Disruption of this barrier's function leads to increased susceptibility to infections and dermatological diseases. Damaged skin can be due to the use of detergents, sunburn or excessive scratching.

View Article and Find Full Text PDF

Background: The European Photopatch Testing Baseline Series (EPTBS) was published in 2013. However, limited data exist regarding the real-world clinical application of the EPTBS.

Objectives: This study aims to describe the photopatch test experience with the EPTBS over 11 years at a tertiary hospital in Spain.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!